Acme Generics is a finished-dose manufacturer based in India. It appears in 46 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), DAV (Vietnam) and BOMRA (BW). Its GMP standing is certified by EMA, ANVISA (Brazil) and FDA (GH). Customs aggregates show $18.3M of exports covering 527 molecules to 19 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Solan, India | 3012112224 |
| HIMACHAL PRADESH, India | Not on file |
| Guru Majra, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 14 | None |
| DAV (Vietnam) | 11 | None |
| BOMRA (BW) | 5 | None |
| DIGEMAPS (DO) | 5 | None |
| CDSCO (India) | 5 | None |
| NCELS (KZ) | 4 | None |
| EMA | None | 4 |
| ANVISA (Brazil) | None | 1 |
| FDA (GH) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.9M | 8 |
| 2025 | Not reported | $18.3M | 19 |
| 2024 | Not reported | $8.6M | 18 |
| 2023 | Not reported | $5.9M | 12 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Acme Generics comes back tiered against every other supplier able to file there.
Start for free